Morgan Health CEO Dan Mendelson spoke with Bloomberg's Katie Greifeld at the JP Morgan Healthcare Conference in San Francisco. He focused on the firm's strategy to control healthcare costs for its clients and the specific investments it is making to achieve that goal. The discussion centered on practical approaches within the corporate health benefits space.

Morgan Health, a JPMorgan Chase subsidiary, targets the employer-sponsored insurance market, which is notoriously expensive and complex. Mendelson's comments signal a push toward value-based care and direct contracting models. This aligns with broader industry trends where large employers seek to bypass traditional insurers to gain cost transparency and better outcomes for their workforce.

The conversation underscores the intense pressure on corporate health spending, which often exceeds inflation. Investors watch Morgan Health's moves for signals on healthcare innovation and potential partnerships. Mendelson's appearance at the influential conference suggests the unit is actively shaping its narrative and deal pipeline for the year ahead.